Publication | Closed Access

Minimal residual core binding factor AMLs by real time quantitative PCR—Initial response to chemotherapy predicts event free survival and close monitoring of peripheral blood unravels the kinetics of relapse

Hematological MalignancyPrognostic BiomarkersMedicineClose MonitoringImmunologyPeripheral Blood UnravelsPathologyOncologyRadiation OncologyCancer Research